Nature study shows: BGM0504, developed with the help of AI and molecular dynamics, has outstanding potency
Shanghai (ots/PRNewswire) – The molecular design strategy and experimental results of Bright Gene’s dual GLP-1/GIP receptor agonist, BGM0504, were published online on July 19, 2024 in Scientific Reports, a journal…